01 4INDIVIOR
01 49687454
01 4Blank
01 4Y
01 42029-08-07
Patent Expiration Date : 2029-08-07
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9687454
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2029-08-07
Patent Expiration Date : 2029-08-07
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9687454
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2029-08-07
Patent Expiration Date : 2029-08-07
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9687454
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2029-08-07
Patent Expiration Date : 2029-08-07
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9687454
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2029-08-07
